Suppr超能文献

解读肠道微生物群对心力衰竭的影响。

Decoding the impact of gut microbiota on heart failure.

作者信息

Zhao Shuhong, Dan Lingxuan, Huang Rong, Shen Zhuoyu, Huang Dan, Wu Pan, Ma Zhenguo

机构信息

Department of Cardiology, Renmin Hospital of Wuhan University, Wuhan, Hubei 430060, China.

Hubei Key Laboratory of Metabolic and Chronic Diseases, Wuhan, Hubei 430060, China.

出版信息

Genes Dis. 2025 Mar 6;12(6):101592. doi: 10.1016/j.gendis.2025.101592. eCollection 2025 Nov.

Abstract

Decreased cardiac output in heart failure leads to intestinal ischemia and increased permeability. Substantial changes occur in the gut microbiota, characterized by a decline in beneficial bacteria and an overgrowth of potentially harmful bacteria. The gut microbiota is intricately linked to prevalent risk factors for heart failure, including hypertension, diabetes, obesity, and renal insufficiency. Furthermore, imbalanced microbiota-derived metabolites enter the bloodstream and may contribute to the progression of heart failure. Ongoing research explores gut microbiota manipulation to alleviate heart failure with probiotics, targeted antibiotics, fecal microbiota transplantation, and dietary adjustments. This review summarizes how gut microbiota participates in heart failure and highlights the emerging promise of modulating gut dysbiosis as a therapeutic approach for managing heart failure.

摘要

心力衰竭时心输出量降低会导致肠道缺血和通透性增加。肠道微生物群发生显著变化,其特征是有益菌减少,潜在有害菌过度生长。肠道微生物群与心力衰竭的常见危险因素密切相关,包括高血压、糖尿病、肥胖和肾功能不全。此外,微生物群衍生的代谢产物失衡进入血液,可能促进心力衰竭的进展。正在进行的研究探索通过益生菌、靶向抗生素、粪便微生物群移植和饮食调整来调节肠道微生物群以缓解心力衰竭。本综述总结了肠道微生物群如何参与心力衰竭,并强调调节肠道生态失调作为治疗心力衰竭的一种方法的新前景。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验